Quick Takeaways
- Parnell has introduced Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution, a Class III controlled veterinary product designed for humane, rapid, and painless euthanasia of dogs, available in 100 mL multi-dose vials.
- The formulation combines 390 mg/mL pentobarbital sodium and 50 mg/mL phenytoin sodium, and includes Rhodamine B dye for clear visual differentiation from therapeutic injectables, enhancing clinical safety and identification.
- Now available across US veterinary practices via distributor partners, the product supports veterinarians in delivering compassionate, dignified end-of-life care with reliability and ease of use.
Why It Matters?
Parnell strengthens its position in the controlled veterinary injectables segment, gaining preference among practices prioritizing safety-differentiated euthanasia agents.
Visual dye innovation reduces medication errors, accelerating adoption in high-volume shelters and clinics while pressuring legacy suppliers on compliance standards.
Humane care branding appeals to pet owners and regulators alike, expanding Parnell’s footprint in companion animal end-of-life protocols nationwide.
Source: Businesswire
